These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31006580)

  • 21. Potential of an altered peptide ligand of lipocalin allergen Bos d 2 for peptide immunotherapy.
    Kinnunen T; Jutila K; Kwok WW; Rytkönen-Nissinen M; Immonen A; Saarelainen S; Närvänen A; Taivainen A; Virtanen T
    J Allergy Clin Immunol; 2007 Apr; 119(4):965-72. PubMed ID: 17335888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on the current status of peptide immunotherapy.
    Larché M
    J Allergy Clin Immunol; 2007 Apr; 119(4):906-9. PubMed ID: 17418662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of immunotherapy in the treatment of asthma].
    Martín Muñoz MF
    Allergol Immunopathol (Madr); 2004; 32(3):133-41. PubMed ID: 15120030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology.
    CMAJ; 1995 May; 152(9):1413-9. PubMed ID: 7728690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Innovative immunotherapies of respiratory allergic diseases].
    Demoly P; Chiriac AM; Michel FB
    Bull Acad Natl Med; 2016 Mar; 200(3):545-7; discussion 557-9. PubMed ID: 28644603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Specific immunotherapy. Hyposensitization with allergens].
    Wedi B; Kapp A
    Hautarzt; 2004 Apr; 55(4):399-407; quiz 408-9. PubMed ID: 15146875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Problems for discussion about bacterial allergens and vaccines and the treatment of bronchial asthma with them].
    Bozhkov B; Dimitrov V
    Vutr Boles; 1989; 28(2):13-9. PubMed ID: 2669336
    [No Abstract]   [Full Text] [Related]  

  • 30. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M; Swoboda I; Marth K; Valenta R
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injection allergen immunotherapy for asthma.
    Abramson MJ; Puy RM; Weiner JM
    Cochrane Database Syst Rev; 2010 Aug; (8):CD001186. PubMed ID: 20687065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRM197-Coupled Der p 2 Peptides Suppress Allergic Airway Inflammation in a Der p 2-Induced Asthma Mouse Model.
    Wang C; Wang L; Chen BC; Yu H; Li L; Zhang KY; Yu B; Wei Z; Chen XF
    Int Arch Allergy Immunol; 2019; 180(3):173-181. PubMed ID: 31537004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation.
    O'Hehir RE; Sandrini A; Anderson GP; Rolland JM
    Curr Med Chem; 2007; 14(21):2235-44. PubMed ID: 17896972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biological engineering for new asthma therapy].
    Van Hage M; Grönlund H; Gafvelin G
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1942-5. PubMed ID: 18681377
    [No Abstract]   [Full Text] [Related]  

  • 35. Allergen immunotherapy for the treatment of respiratory allergies in the elderly.
    Hur GY; Lee JH; Park HS
    Curr Opin Allergy Clin Immunol; 2017 Aug; 17(4):304-308. PubMed ID: 28525399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of peptide immunotherapy in allergy and asthma.
    Ali FR; Kay AB; Larché M
    Curr Allergy Asthma Rep; 2002 Mar; 2(2):151-8. PubMed ID: 11892095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthma.
    Kohno Y; Minoguchi K; Oda N; Yokoe T; Yamashita N; Sakane T; Adachi M
    J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):927-34. PubMed ID: 9847433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7.
    Westritschnig K; Focke M; Verdino P; Goessler W; Keller W; Twardosz A; Mari A; Horak F; Wiedermann U; Hartl A; Thalhamer J; Sperr WR; Valent P; Valenta R
    J Immunol; 2004 May; 172(9):5684-92. PubMed ID: 15100313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is hyposensitization still an adequate procedure in treatment of bronchial asthma?].
    Baur X
    Pneumologie; 1992 Mar; 46(3):89-91. PubMed ID: 1584737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Allergen Immunotherapy in Children Disease Modifying? A Review of the Evidence.
    Rudman Spergel AK; Minnicozzi M; Wheatley LM; Togias A
    Curr Allergy Asthma Rep; 2018 Jul; 18(9):47. PubMed ID: 29995257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.